Clinical Research Directory
Browse clinical research sites, groups, and studies.
AI-Assisted Microbiome Analysis for Evaluating the Efficacy of MPRO3 and Gut Environmental Changes in Colon Cancer Surgery Patients
Sponsor: hy Co., LTD.
Summary
The goal of this clinical trial is to evaluate the effects of MPRO3(probiotics mixture) supplementation on surgical outcomes and gut health in patients undergoing surgery for colon cancer.The main question is whether MPRO3 supplementation before and after surgery can reduce postoperative infectious complications compared with placebo.Participants will take either MPRO3 or a placebo once daily for 13 weeks, from 1 week before surgery to 12 weeks after surgery. Researchers will compare the two groups to assess postoperative infectious complications, other clinical outcomes, and changes in the gut microbiome.
Official title: AI-Assisted Microbiome Analysis for Evaluating the Efficacy of MPRO3 and Gut Environmental Changes in Colon Cancer Surgery Patients: A 13-Week, Randomized, Double-Blind, Placebo-Controlled Trial (AI-MPRO3 Study)
Key Details
Gender
All
Age Range
20 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2026-08-04
Completion Date
2028-04-12
Last Updated
2026-08-28
Healthy Volunteers
No
Conditions
Interventions
Placebo
Participants will receive one placebo capsule orally once daily after breakfast for 13 weeks.
MPRO3
Participants will receive one MPRO3 capsule orally once daily after breakfast for 13 weeks.
Locations (1)
Seoul ST. Mary's Hospital
Seoul, Seoul, South Korea